Mainz Biomed's eAArly DETECT 2 trial for their colorectal cancer test is underway 🔬 Looks like they're making big strides in early detection and prevention of CRC. Keep an eye on $MYNZ, this could be big! $GTEC $GM $TSLA $MLGO $TNXP
Monte Rosa Therapeutics' (GLUE) blowout Q4 earnings show they're a biotech ($MYNZ) on the rise. Strong revenues, earnings beat - signs of great things to come 🚀 $TSLA $LYT $AAPL $MLGO $CELH
BREAKING 📰 $MYNZ has enrolled the first patient in their eAArly DETECT 2 study to validate their next-gen CRC test with AI & FIT. Aim is to move from screening to prevention. Results expected late 2025 - exciting progress! 🤖 $LYT $NIO $TSLA $COOP $AMZN
BREAKING: Mainz Biomed $MYNZ just enrolled the first patient in a major new colorectal cancer study! This next-gen test combines mRNA biomarkers, AI, and FIT to validate prior results and advance cancer prevention. Exciting times ahead 🔍🩺 $HOOD $TSLA $AMD
BREAKING NEWS! 🚨 Mainz Biomed ($MYNZ) just enrolled the first patient in their eAArly DETECT 2 study - a major step in their mission to eliminate colorectal cancer. This AI-powered test could revolutionize early detection. This stock is one to watch at $8.1! $TSLA $GM $AAPL
BREAKING: $MYNZ just announced the first patient enrolled in eAArly DETECT 2 study for their next-gen colorectal cancer test! 🚨 This major milestone brings us one step closer to detecting precancerous lesions early & preventing cancer. Exciting times ahead! 🔍 $HOOD $GTEC $TSLA
Mainz Biomed ($MYNZ) just enrolled the first patient in their groundbreaking CRC test study! 🚀 This is a major step in their mission to eliminate colorectal cancer. Don't miss out on this opportunity - this stock is about to take off! $GME $DRMA $GM
Exciting news! $MYNZ is enrolling patients for its next-gen colorectal cancer test 🔬 Aiming to detect precancerous lesions early and prevent cancer. With promising prior results, this is a major step towards their mission to eliminate CRC. Definitely one to... $GTEC $TSLA $NVDA
BREAKING NEWS! 🚨 Mainz Biomed $MYNZ has enrolled the first patient in its eAArly DETECT 2 study to validate its CRC test. This advanced tech aims to detect precancerous lesions early, a major step in eliminating colorectal cancer. Exciting times ahead! $AAPL $LYT $GM
BREAKING: Mainz Biomed ($MYNZ) just enrolled the first patient in eAArly DETECT 2 - a pivotal trial for their AI-powered colorectal cancer test. This major milestone brings us one step closer to early CRC detection and prevention. 🔬 $DRMA $AMD $AAPL
Insider info - $MYNZ is about to change the game in colorectal cancer detection 🔍. Enrollment started for their next-gen CRC test, aiming to find precancerous lesions early. Current price $3.54, target $8.1 (+128.5%). This is a game-changer, don't miss out! 💰 $GM $DRMA $AAPL
Yo, les gars! Vous cherchez des $GAINZ ? $MYNZ est le fuel, c'est le feu! Foncez, il est encore pas cher 😎 À $3,97, ça va exploser jusqu'à $8,10. Je ne vous conseille pas, je vous l'ordonne : $MYNZ dans votre portefeuille ! #YOLO#FOMO#HODL $NVDA $GTEC $AMD
Bon, les amis. $MYNZ est en feu et je ne peux pas arrêter de le regarder ! 🔥 Avec un prix actuel de 3,97 $ et un objectif de 8,10 $, ce serait un crime de ne pas s'y mettre maintenant. Rejoignez-moi dans ce voyage palpitant ! #investissement#opportunité... $AAPL $HOOD $AMD
Regarde le cours de $MYNZ, les gars! À seulement 4,27 $, c'est une affaire en or. Il va décoller jusqu'à 8,10 $, je le sens ! N'hésite pas, charge-toi en $MYNZ. $COIN $PLUG $FCEL $SE
Vous cherchez la prochaine grosse tendance? $MYNZ est là pour vous! À $4.27, c'est une opportunité en or 💰 Avec un objectif de $8.10, vos gains seront astronomiques! N'attendez pas, investissez maintenant dans $MYNZ, $SHOP, $PYPL et $COIN.